An investigation for investors in NYSE:EBS shares over potential securities laws violations by Emergent Biosolutions was announced and NYSE:EBS stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 07/06/2016 --An investigation on behalf of investors of Emergent Biosolutions Inc (NYSE:EBS) shares over potential securities laws violations by Emergent Biosolutions in connection certain financial statements was announced.

Investors who purchased shares of Emergent Biosolutions Inc (NYSE:EBS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Emergent Biosolutions Inc (NYSE:EBS) concerning whether a series of statements by Emergent Biosolutions regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Emergent Biosolutions Inc reported that its annual Total Revenue rose from $281.89 million in 2012 to $522.79 million in 2015 and that its Net Income increased from $23.52 million in 2012 to $62.87 million in 2015. Shares of Emergent Biosolutions Inc (NYSE:EBS) grew from $13.20 per share in April 2013 to as high as $44.38 per share on June 7, 2016. Since then NYSE:EBS shares declined to $27.01 per share on June 28, 2016.

On July 5, 2016, NYSE:EBS shares closed at $28.78 per share.

Those who purchased shares of Emergent Biosolutions Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com